The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance

Bibliographic Details
Main Authors: Crowley Anna, Kim Han W, Parker Michele, Spatz Deneen, Hayes Brenda, Bhatti Lubna, Jensen Christoph J, Ngo Jessica, Papalas John A, Pun Patrick, Middleton John P, Judd Robert M, Kim Raymond J
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Journal of Cardiovascular Magnetic Resonance
id doaj-f5a87c2ea15049f6b97d03b046972e21
record_format Article
spelling doaj-f5a87c2ea15049f6b97d03b046972e212020-11-24T23:33:00ZengBMCJournal of Cardiovascular Magnetic Resonance1097-66471532-429X2012-02-0114Suppl 1P4810.1186/1532-429X-14-S1-P48The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonanceCrowley AnnaKim Han WParker MicheleSpatz DeneenHayes BrendaBhatti LubnaJensen Christoph JNgo JessicaPapalas John APun PatrickMiddleton John PJudd Robert MKim Raymond J
collection DOAJ
language English
format Article
sources DOAJ
author Crowley Anna
Kim Han W
Parker Michele
Spatz Deneen
Hayes Brenda
Bhatti Lubna
Jensen Christoph J
Ngo Jessica
Papalas John A
Pun Patrick
Middleton John P
Judd Robert M
Kim Raymond J
spellingShingle Crowley Anna
Kim Han W
Parker Michele
Spatz Deneen
Hayes Brenda
Bhatti Lubna
Jensen Christoph J
Ngo Jessica
Papalas John A
Pun Patrick
Middleton John P
Judd Robert M
Kim Raymond J
The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
Journal of Cardiovascular Magnetic Resonance
author_facet Crowley Anna
Kim Han W
Parker Michele
Spatz Deneen
Hayes Brenda
Bhatti Lubna
Jensen Christoph J
Ngo Jessica
Papalas John A
Pun Patrick
Middleton John P
Judd Robert M
Kim Raymond J
author_sort Crowley Anna
title The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
title_short The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
title_full The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
title_fullStr The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
title_full_unstemmed The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
title_sort incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
publisher BMC
series Journal of Cardiovascular Magnetic Resonance
issn 1097-6647
1532-429X
publishDate 2012-02-01
work_keys_str_mv AT crowleyanna theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT kimhanw theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT parkermichele theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT spatzdeneen theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT hayesbrenda theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT bhattilubna theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT jensenchristophj theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT ngojessica theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT papalasjohna theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT punpatrick theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT middletonjohnp theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT juddrobertm theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT kimraymondj theincidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT crowleyanna incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT kimhanw incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT parkermichele incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT spatzdeneen incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT hayesbrenda incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT bhattilubna incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT jensenchristophj incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT ngojessica incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT papalasjohna incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT punpatrick incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT middletonjohnp incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT juddrobertm incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
AT kimraymondj incidenceofnephrogenicsystemicfibrosisinsubjectsreceivinggadoversetamideforcardiovascularmagneticresonance
_version_ 1725532367860269056